Gábor Rubovszky

Gábor Rubovszky

National Institute of Oncology, Hungary - Budapest / Hungary
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4411302
-
person_outline Gábor Rubovszky's MOST POPULAR ARTICLES
1-) Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast CancerF André, E Ciruelos, G Rubovszky, M Campone, S Loibl, HS Rugo, ...New England Journal of Medicine 380 (20), 1929-1940, 201913942019
2-) Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355 …J Cortes, DW Cescon, HS Rugo, Z Nowecki, SA Im, MM Yusof, C Gallardo, ...The Lancet 396 (10265), 1817-1828, 20206352020
3-) Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival …F André, EM Ciruelos, D Juric, S Loibl, M Campone, IA Mayer, ...Annals of Oncology 32 (2), 208-217, 20211972021
4-) Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla–Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast …Á Sávolt, G Péley, C Polgár, N Udvarhelyi, G Rubovszky, E Kovács, ...European Journal of Surgical Oncology (EJSO) 43 (4), 672-679, 20172942017
5-) Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyEL Mayer, AC Dueck, M Martin, G Rubovszky, HJ Burstein, ...The lancet oncology 22 (2), 212-222, 20212492021